To the best of our knowledge, this study may be the first to report the effects of treatment with dopamine on the expression profiles of NF-κB subunits in glioma and to demonstrate the mechanisms underlying the anti-cancer effects of dopamine both in vitro and in vivo. Here, NFKB1 is linked to glioma.